🚀 VC round data is live in beta, check it out!
- Public Comps
- Omer-Decugis
Omer-Decugis Valuation Multiples
Discover revenue and EBITDA valuation multiples for Omer-Decugis and similar public comparables like BioHarvest Sciences, Orior, Apetit, NWF Group and more.
Omer-Decugis Overview
About Omer-Decugis
Omer-Decugis & Cie specializes in the import, ripening and distribution of fresh fruits and vegetables. Its flagship products are bananas, pineapples, mango and ripened fruits, small exotics, Premium tropical fruits and vegetables.
Founded
1850
HQ

Employees
N/A
Website
Financials (LTM)
EV
$97M
Omer-Decugis Financials
Omer-Decugis reported last 12-month revenue of $352M and EBITDA of $15M.
In the same LTM period, Omer-Decugis generated $15M in EBITDA and $8M in net income.
Revenue (LTM)
Omer-Decugis P&L
In the most recent fiscal year, Omer-Decugis reported revenue of $339M and EBITDA of $14M.
Omer-Decugis expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $352M | XXX | $339M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $33M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA | $15M | XXX | $14M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $8M | XXX | $7M | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Omer-Decugis Stock Performance
Omer-Decugis has current market cap of $96M, and enterprise value of $97M.
Market Cap Evolution
Omer-Decugis' stock price is $11.29.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $97M | $96M | 0.0% | XXX | XXX | XXX | $0.88 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOmer-Decugis Valuation Multiples
Omer-Decugis trades at 0.3x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
Omer-Decugis Financial Valuation Multiples
As of March 16, 2026, Omer-Decugis has market cap of $96M and EV of $97M.
Equity research analysts estimate Omer-Decugis' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Omer-Decugis has a P/E ratio of 11.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $96M | XXX | $96M | XXX | XXX | XXX |
| EV (current) | $97M | XXX | $97M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | 6.5x | XXX | 6.8x | XXX | XXX | XXX |
| EV/EBIT | 8.3x | XXX | 8.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.9x | XXX | XXX | XXX |
| P/E | 11.3x | XXX | 12.8x | XXX | XXX | XXX |
| EV/FCF | 29.8x | XXX | 101.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Omer-Decugis Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Omer-Decugis Margins & Growth Rates
Omer-Decugis' revenue in the last 12 month grew by 10%.
Omer-Decugis' rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Omer-Decugis' rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Omer-Decugis Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 11% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 30% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Omer-Decugis Public Comps
See public comps and valuation multiples for other Food & Beverages and Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BioHarvest Sciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Orior | XXX | XXX | XXX | XXX | XXX | XXX |
| Apetit | XXX | XXX | XXX | XXX | XXX | XXX |
| NWF Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Zevia | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Omer-Decugis M&A Activity
Omer-Decugis acquired XXX companies to date.
Last acquisition by Omer-Decugis was on XXXXXXXX, XXXXX. Omer-Decugis acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Omer-Decugis
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOmer-Decugis Investment Activity
Omer-Decugis invested in XXX companies to date.
Omer-Decugis made its latest investment on XXXXXXXX, XXXXX. Omer-Decugis invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Omer-Decugis
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Omer-Decugis
| When was Omer-Decugis founded? | Omer-Decugis was founded in 1850. |
| Where is Omer-Decugis headquartered? | Omer-Decugis is headquartered in France. |
| Is Omer-Decugis publicly listed? | Yes, Omer-Decugis is a public company listed on Euronext Paris. |
| What is the stock symbol of Omer-Decugis? | Omer-Decugis trades under ALODC ticker. |
| When did Omer-Decugis go public? | Omer-Decugis went public in 2021. |
| Who are competitors of Omer-Decugis? | Omer-Decugis main competitors are BioHarvest Sciences, Orior, Apetit, NWF Group. |
| What is the current market cap of Omer-Decugis? | Omer-Decugis' current market cap is $96M. |
| What is the current revenue of Omer-Decugis? | Omer-Decugis' last 12 months revenue is $352M. |
| What is the current revenue growth of Omer-Decugis? | Omer-Decugis revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Omer-Decugis? | Current revenue multiple of Omer-Decugis is 0.3x. |
| Is Omer-Decugis profitable? | Yes, Omer-Decugis is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Omer-Decugis? | Omer-Decugis' last 12 months EBITDA is $15M. |
| What is Omer-Decugis' EBITDA margin? | Omer-Decugis' last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Omer-Decugis? | Current EBITDA multiple of Omer-Decugis is 6.5x. |
| What is the current FCF of Omer-Decugis? | Omer-Decugis' last 12 months FCF is $3M. |
| What is Omer-Decugis' FCF margin? | Omer-Decugis' last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of Omer-Decugis? | Current FCF multiple of Omer-Decugis is 29.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.